期刊文献+

就诊时血清白蛋白水平对STEMI患者冠状动脉自发再通的影响

下载PDF
导出
摘要 心肌梗死是由于冠状动脉粥样硬化引发了血栓,使冠状动脉的管腔发生闭塞,进而致使心肌发生缺血所致,具有发病率及病死率高等特点[1].研究结果显示约有1/5急性ST段抬高型心肌梗死(seg-mentelevate myocareidal infarction,STEMI)患者在进行急诊冠状动脉造影时其梗死溶栓临床试验(throm-bolysis in myocardial infarctio,TIMI)血流分级已达到2~3级,这提示这类患者发生梗死的动脉有可能会自发再通,其预后明显优于梗死动脉完全闭塞的患者[2,3].白蛋白不仅可以调节血管渗透压和运转多种外源性及内源性物质,还会对许多药物的药代动力带来一定的影响[4,5].本研究探讨STEMI患者就诊时血清白蛋白状况对梗死动脉自发再通的影响.
出处 《全科医学临床与教育》 2020年第2期157-158,161,共3页 Clinical Education of General Practice
  • 相关文献

参考文献5

二级参考文献23

  • 1吴德光,李清贤,王彦富,石胜伟,李莎.胰岛素抵抗指数及高敏C-反应蛋白对急性冠脉综合征冠脉病变的预测价值[J].西安交通大学学报(医学版),2012,33(3):329-331. 被引量:12
  • 2韩雅玲.中国经皮冠状动脉介入治疗指南2012(简本)[J].中国医学前沿杂志(电子版),2012,4(12):50-59. 被引量:133
  • 3Uriel N, Moravsky G, Blatt A, et al. ST myocardial infarction with spontaneous coronary reperfusion. Harefuah, 2006,145 : 367- 370,397,396.
  • 4Stone GW, Cox D, Garcia E, et al. Normal flow (TIMI-3) be- fore mechanical reperfusion therapy is an independent determi- nant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation, 2001,104:636-641.
  • 5De Luca G, Suryapranata H, Stone GW, et al. Abciximab as ad- junctive therapy to reperfusion in acute ST-segment elevation my- ocardial infarction: a meta-analysis of randomized trials. JAMA, 2005,293 : 1759-1765.
  • 6Cutlip DE, Cove C J, Irons D, et al. Emergency room adminis- tration of eptifibatide before primary angioplasty for ST elevation acute myocardial infarction and its effect on baseline coronary flow and procedure outcomes. Am J Cardiol,2001,88:A6,62-64.
  • 7Steg PG, James SK, Atar D, et al. ESC Guidelines for the man- agement of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J, 2012,33 : 2569-2619.
  • 8Lee DP, Herity NA, Hiatt BL, et al. Adjunctive platelet glyco- protein IIb/III a receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes : results of the Tlrofiban Given in the Emergency Room before Primary Angio- plasty (TIGER -PA) pilot trial. Circulation,2003,107 : 1497 - 1501.
  • 9Montalescot G, Barragan P, Wittenberg O, et al. Platelet glyco- protein II b/m a inhibition with coronary stenting for acute my- ocardial infarction. N Engl J Med,2001,344:1895-1903.
  • 10Warnholtz A, Ostad MA, Heitzer T, et al. Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunc- tion in patients with stable coronary artery disease. Am J Cardiol, 2005,95 : 20-23.

共引文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部